Polatuzumab vedotin, CAS [[1313206-42-6]]

Produktübersicht

• Artikelname: Polatuzumab vedotin, CAS [[1313206-42-6]]
• Artikelnummer: MCE-HY-132253
• Hersteller Artikelnummer: HY-132253
• Alternativnummer: MCE-HY-132253-5MG,MCE-HY-132253-25MG,MCE-HY-132253-1MG,MCE-HY-132253-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Polatuzumab vedotin is an antibody-drug conjugate targeting CD79b. It contains a humanized anti-CD79b IgG1 monoclonal antibody linked to monomethyl auristatin E (MMAE), a potent microtubule inhibitor. The antibody portion is Polatuzumab (HY-P99042), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Polatuzumab vedotin has the potential for the research of Large B-cell lymphomas (LBCL)[1].

Produkteigenschaften

• Molekulargewicht: 150000 (average)
• Reinheit: 99.37
• CAS Nummer: [1313206-42-6]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs),Transmembrane Glycoprotein

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: ADC Related